Armistice Capital, LLC Nls Pharmaceutics Ltd. Transaction History

Armistice Capital, LLC

  • $6.02 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$0.11 - $0.27 $15,290 - $37,530
139,000 Added 6.4%
2,311,000 $508,000
Q1 2024

May 15, 2024
BUY
$0.16 - $0.59 $347,520 - $1.28 Million
2,172,000 New
2,172,000 $390,000
Q2 2022

Aug 15, 2022
BUY
$0.53 - $1.36 $644,697 - $1.65 Million
1,216,411 New
1,216,411 $714,000

About NLS Pharmaceutics Ltd.

NLSP Quotes by TradingView
  • Ticker NLSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,349,900
  • Market Cap $55.5M
  • Description
  • NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, suc...
More about NLSP
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email